Kaposiform hemangioendothelioma of the thigh: a case report [PDF]
Kaposiform hemangioendothelioma is a rare, locally aggressive or borderline vascular tumor that typically affects infants. It presents as a purpuric cutaneous lesion and may be associated with life-threatening coagulation disorders, such as the Kasabach ...
Margarida Morgado, MD +5 more
doaj +3 more sources
Multidisciplinary management of a neonate with kaposiform hemangioendothelioma with extensive cranial fossa destruction [PDF]
Kaposiform hemangioendothelioma is a rare, benign, locally destructive vascular tumor. Kasabach–Merritt phenomenon, a consumptive coagulopathy, is a life-threatening complication associated with kaposiform hemangioendothelioma.
Amelia Aynaz Khoei +5 more
doaj +3 more sources
Kaposiform hemangioendothelioma complicated by Kasabach–Merritt phenomenon in an infant girl [PDF]
Key Clinical Message We report a successful treatment course of an infant with mediastinal Kaposiform hemangioendothelioma. As the current complex of diseases is rare and calls for highly specialized treatment, large prospective studies are lacking. This
Louise Helligsø +2 more
doaj +3 more sources
Kaposiform hemangioendothelioma: Diagnosis and treatment [PDF]
Kaposiform hemangioendothelioma (KHE) is a rare borderline vascular tumor that occurs primarily during infancy and childhood. The tumor typically originates in the skin and exhibits invasive growth into deeper tissues, often manifesting as a firm, poorly
Yi Tian +5 more
doaj +3 more sources
A Case of Superficial Kaposiform Hemangioendothelioma Treated with Oral Propranolol Combined with Topical Sirolimus [PDF]
Nan Dang,1 Yunqing Ren2 1Shanghai Children’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2Children’s Hospital of Zhejiang University School of Medicine, Hangzhou, People’s Republic of ...
Nan Dang
exaly +4 more sources
Nasal kaposiform hemangioendothelioma: a rare disease in a rare location—a review article with a case report [PDF]
Kaposiform hemangioendothelioma is a rare vascular tumor of endothelial origin that occurs during the first decade of life. It is locally aggressive, with a tendency for local invasion and spread to regional lymph nodes.
Feras Alkholaiwi, Ji Yun Choi
doaj +2 more sources
Prenatal Diagnosis and Management of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Imaging Features and First Experience With Maternal Sirolimus Therapy. [PDF]
ABSTRACT Objective To describe the prenatal diagnosis, evolution, and perinatal management of kaposiform hemangioendothelioma (KHE) complicated by the Kasabach–Merritt phenomenon (KMP), and to report the first documented use of maternal sirolimus therapy (MST) in this setting. Methods We retrospectively reviewed four fetuses with a prenatal soft‐tissue
Fraissenon A +11 more
europepmc +2 more sources
Bleomycin electrosclerotherapy for kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an adult. [PDF]
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 551-553, April 2026.
Veeser J +11 more
europepmc +2 more sources
A Rare Case of Neonatal Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon Presenting as an Abdominal Mass Without Cutaneous Manifestations. [PDF]
Kaposiform hemangioendothelioma (KHE) is a rare vascular neoplasm that typically presents in infancy or early childhood, classified as a locally aggressive/borderline vascular tumor. It most commonly involves superficial and deep soft tissues, often demonstrating infiltrative growth into adjacent muscle and bone, whereas retroperitoneal or ...
Park SY +5 more
europepmc +2 more sources
Successful Management of Neonatal and Infantile Kaposiform Hemangioendothelioma with Low-Dose Sirolimus Therapy [PDF]
Sirolimus is reportedly effective for kaposiform hemangioendothelioma. However, data on the efficacy of low-dose sirolimus therapy remain limited. This report presents two cases of neonatal and infantile kaposiform hemangioendothelioma associated with ...
Yoshimasa Uematsu, MD +9 more
doaj +2 more sources

